Remission according to different composite disease activity indices in biologic-nave patients with rheumatoid arthritis treated with abatacept or infliximab plus methotrexate

Category Primary study
JournalArthritis and Rheumatism
Year 2011
This article has no abstract
Epistemonikos ID: 55a048f2165ec47dbea22af3630c8268bfba3f98
First added on: Feb 05, 2025